Hong Zhao

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Shandong Tumor Hospital, Shandong First Medical University · ORCID：0000-0003-0323-5190

发表论文 127 篇 · 总被引 4328 次 · h-index 33

代表论文

• Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial (2023 · The Lancet Oncology · 被引 455)
• HBV integrations reshaping genomic structures promote hepatocellular carcinoma (2024 · Gut · 被引 51)
• Prediction of Clinical Precision Chemotherapy by Patient‐Derived 3D Bioprinting Models of Colorectal Cancer and Its Liver Metastases (2023 · Advanced Science · 被引 42)
• Real-Time Reconstruction of HIFU Focal Temperature Field Based on Deep Learning (2024 · BME Frontiers · 被引 16)
• Association Between MRI Radiomics and Intratumoral Tertiary Lymphoid Structures in Intrahepatic Cholangiocarcinoma and Its Prognostic Significance (2023 · Journal of Magnetic Resonance Imaging · 被引 14)
• The GRAPHS-CRAFITY score: a novel efficacy predictive tool for unresectable hepatocellular carcinoma treated with immunotherapy (2024 · La radiologia medica · 被引 7)